Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Irritable Bowel Syndrome, January 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 130 articles: HTML format

Single Articles

1. LORSCH ZS, Liddle RA
   Mechanisms and clinical implications of gut-brain interactions.
   J Clin Invest. 2026;136:e196346.
   Abstract
   
   
2. ZHANG HM, Zhang Y, Luo GJ, Zhang AX, et al
   Human umbilical cord mesenchymal stem cells alleviated diarrhea-type irritable bowel syndrome by improving intestinal function.
   World J Stem Cells. 2025;17:112100.
   Abstract
   
   
3. SHANG S, Liu Y, Bai QL, Zhang Z, et al
   Latent myofascial trigger point injection improves symptoms in functional gastrointestinal disorders.
   World J Gastrointest Surg. 2025;17:111359.
   Abstract
   
   
4. VASSALOS CM, Koutelekos I, Vassalou E
   Assessment of Prevalence of Dientamoeba fragilis and Its Associated Factors Compared to Those of Giardia lamblia and Blastocystis sp. Among Greek Patients with Suspicion of Intestinal Parasitosis.
   Adv Exp Med Biol. 2026;1490:181-189.
   Abstract
   
   
5. WU W, Qiu Y, Liang F, Lu W, et al
   Acupuncture and moxibustion in irritable bowel syndrome: a mechanistic exploration from heart rate variability to cardiac metabolism.
   Front Neurol. 2025;16:1716708.
   Abstract
   
   
6. SZURA E, Poniewierka E
   Impact of physical activity and selected relaxation techniques on the quality of life of female patients with irritable bowel syndrome.
   Prz Gastroenterol. 2025;20:439-442.
   Abstract
   
   
7. SINGH A, Singh R
   The gastrointestinal endothelin system: receptors, cellular actions, and involvement in gastrointestinal disorders.
   Prz Gastroenterol. 2025;20:372-381.
   Abstract
   
   
8. BALLENA-CAICEDO J, Zuzunaga-Montoya FE, Valladolid-Sandoval LAM, Valladares-Garrido MJ, et al
   Prevalence of irritable bowel syndrome in medical students: a systematic review and meta-analysis.
   Front Med (Lausanne). 2025;12:1714085.
   Abstract
   
   
9. CHIU YT, Lee FJ, Kuo CY, Yang PC, et al
   The Post-Cholecystectomy Gut Microbiota Follows a Time-Varying Change-A Pilot Study.
   JGH Open. 2025;9:e70329.
   Abstract
   
   
10. LEPCZYNSKA M
    The interplay between Blastocystis and human gut microbiota.
    Ann Parasitol. 2025;71:171-184.
    Abstract
    
    
11. CHAVHAN PKB, Sayeed MS, Saiyad SS, Shah MN, et al
    Lactose Intolerance in Irritable Bowel Syndrome: Prevalence, Subtype Correlations, and Clinical Predictors in an Indian Cohort.
    Cureus. 2025;17:e97697.
    Abstract
    
    
12. PUSHADAPU VVSK, Srikar G
    Development and evaluation of chitosan-xanthan gum-based controlled release nanoparticles of mebeverine hydrochloride for targeted IBS therapy: in silico, in vitro, and in vivo investigations.
    Daru. 2025;34:6.
    Abstract
    
    
13. POPA IV, Dranga M, Nedelciuc O, Mihai C, et al
    Artificial Intelligence Methods for the Differential Diagnosis of Irritable Bowel Syndrome and Inflammatory Bowel Disease: A Systematic Review.
    J Gastrointestin Liver Dis. 2025;34:510-514.
    Abstract
    
    
14. MOU JJ, Xu L, Luo YF, Tao QF, et al
    Assessing the Efficacy and Safety of Multiple Drugs for IBS-C: A Systematic Review and Network Meta-Analysis.
    J Gastrointestin Liver Dis. 2025;34:503-509.
    Abstract
    
    
15. DU Y, Xu H, Xiong J, Wang Z, et al
    Tracing Evolution of Hotspots and Frontiers: A Bibliometric Exploration of Acupuncture Therapy in Irritable Bowel Syndrome.
    J Multidiscip Healthc. 2025;18:8133-8152.
    Abstract
    
    
16. SAHU SK, Nath P, Mallick B, Praharaj D, et al
    Pharmacotherapy for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Beyond Conventional Laxatives: A Narrative Review.
    Cureus. 2025;17:e97523.
    Abstract
    
    
17. GUAGNOZZI D, Gonzalez-Castro AM, Zabana Y, Fernandez-Banares F, et al
    Integrated Multi-Omic Analysis Identifies Altered Colonic Brush Border Profile as a Key Feature of Microscopic Colitis.
    United European Gastroenterol J. 2026;14:e70156.
    Abstract
    
    
18. MIDENFJORD I, Khadija M, Sundelin E, Trindade IA, et al
    Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project.
    United European Gastroenterol J. 2026;14:e70157.
    Abstract
    
    
19. CAI E, Kouznetsova VL, Tsigelny IF
    Metabolomics-Based Machine Learning Diagnostics of Post-Acute Sequelae of SARS-CoV-2 Infection.
    Metabolites. 2025;15:801.
    Abstract
    
    
20. AL-MADHAGI H
    A Systems Biology and Drug Repositioning Approach for the Analysis of Mutual Genes Between Celiac Disease and Irritable Bowel Syndrome.
    Biomed Res Int. 2025;2025:8227229.
    Abstract
    
    
21. SUN F, Li H, Gong B, Hui S, et al
    Investigating the Causal Relationship and Shared Genetic Basis Between Major Depression Disorder and Eight Types of Gastrointestinal Diseases.
    Genet Res (Camb). 2025;2025:6931243.
    Abstract
    
    
22. HSU LH, Chou YP, Shen TL, Wieczorek D, et al
    Otilonium bromide exhibits novel antifungal activity against Candida albicans via regulating iron homeostasis.
    Virulence. 2026;17:2609407.
    Abstract
    
    
23. TACK C, Van den Houte K, Besard L, Capiau L, et al
    A study on the utility of inflammatory biomarkers in primary care irritable bowel syndrome: a sub analysis of the DOMINO randomized trial.
    BMC Gastroenterol. 2025 Dec 23. doi: 10.1186/s12876-025-04494.
    Abstract
    
    
24. DOWRICK JM, Roy NC, Carco C, James SC, et al
    Integrated multi-omic and symptom clustering reveals lower-gastrointestinal disorders of gut-brain interaction heterogeneity.
    Gut Microbes. 2026;18:2604871.
    Abstract
    
    
25. PORCHIA DD, Wang Y, Zhou Z, Chen M, et al
    Cannabis use, microbial diversity and Dialister abundance in older adults with HIV: A cross-sectional study.
    HIV Med. 2025 Dec 22. doi: 10.1111/hiv.70180.
    Abstract
    
    
26. PROSPERO L, Riezzo G, Laselva G, D'Attoma B, et al
    Somatization, psychological distress, and quality of life across fibromyalgia, irritable bowel syndrome, and their comorbid phenotype: a cross-sectional clinical comparison.
    Front Psychol. 2025;16:1709017.
    Abstract
    
    
27. ELKALLA MA, Ali YG, Ewais MM, Taha AS, et al
    Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review.
    Clin Rheumatol. 2025 Dec 22. doi: 10.1007/s10067-025-07861.
    Abstract
    
    
28. VON MUHLENBROCK C, Aronsohn F, Quera R, Madrid AM, et al
    The role of dietary fiber in the gastrointestinal tract: when, how and why?
    Best Pract Res Clin Gastroenterol. 2025;79:102080.
    Abstract
    
    
29. BIESIEKIERSKI JR
    Clinical utility of gluten restriction in gastrointestinal disorders: Evidence, practice, and reappraisal of non-coeliac gluten sensitivity.
    Best Pract Res Clin Gastroenterol. 2025;79:102086.
    Abstract
    
    
30. BERSCHBACK M, Abber S, Smith J, Staller K, et al
    Avoidant/restrictive food intake disorder in disorders of gut-brain interaction.
    Best Pract Res Clin Gastroenterol. 2025;79:102078.
    Abstract
    
    
31. VAN DEN HOUTE K
    Dietary approaches in functional bowel disorders.
    Best Pract Res Clin Gastroenterol. 2025;79:102077.
    Abstract
    
    
32. BUTT MF, Reghefaoui MH, Benedict AS, Reghefaoui M, et al
    Irritable Bowel Syndrome in Inflammatory Bowel Disease: An Evidence-Based Practical Review.
    J Clin Med. 2025;15:116.
    Abstract
    
    
33. CHOJNACKI C, Medrek-Socha M, Chojnacki J, Gasiorowska A, et al
    Multi-Strain Probiotic Improves Tryptophan Metabolism and Symptoms in Chronic Fatigue Syndrome Patients with Co-Occurring Irritable Bowel Syndrome: An Open-Label Pilot Study.
    Nutrients. 2026;18:174.
    Abstract
    
    
34. RUTA F, Avram C, Mardale E, Maior R, et al
    Histamine-Producing Intestinal Dysbiosis and Its Role in Lower Urinary Tract Infections and Irritable Bowel Syndrome in Young Women.
    Nutrients. 2025;18:16.
    Abstract
    
    
35. CADUNGOG MEGT, Tayo LL
    Microinflammation-Driven Gene Expression Dynamics in the Pathogenesis of Metabolic Disorders and Cancer.
    Biology (Basel). 2025;15:19.
    Abstract
    
    
36. PENG F, Xu K, Ba Q, Bi H, et al
    Investigating the causal roles of cholesterol and triglyceride subfractions across lipoproteins in irritable bowel syndrome: a Mendelian randomization study.
    Metabol Open. 2025;29:100434.
    Abstract
    
    
37. TAO QF, Hua C, Zhuo X, Mou JJ, et al
    Face-to-Face Versus Digital, Telephone-Delivered, and Self-Help Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Systematic Review and Bayesian Indirect Treatment Comparison Meta-Analysis.
    J Med Internet Res. 2026;28:e75833.
    Abstract
    
    
38. KERCKHOVE N, Zerbib F, Chambaz M, Mion F, et al
    Ethosuximide and Irritable Bowel Syndrome-Related Abdominal Pain: A Randomized Clinical Trial.
    JAMA Netw Open. 2026;9:e2551368.
    Abstract
    
    
39. BADWEI N, Abdelsalam A, Wassif GO, El-Din HES, et al
    Frequency and predictive role of intestinal parasitic infections with irritable bowel syndrome in Egyptian patients: a case-control study.
    Infection. 2026 Jan 8. doi: 10.1007/s15010-026-02724.
    Abstract
    
    
40. ERLITA D, Shatri H, Fauzi A, Abdullah M, et al
    The Role of Probiotics in Depression and Quality of Life in Patients with Irritable Bowel Syndrome.
    Acta Med Indones. 2025;57:485-492.
    Abstract
    
    
41. POSLUSNEY MS, Li Q, Buchler IP, Huang Y, et al
    Development of a Novel Benzodiazepine to Delineate Peripheral GABA-A Signaling Mechanisms in Visceral Pain Syndromes.
    Cell Mol Gastroenterol Hepatol. 2026 Jan 5:101704.
    Abstract
    
    
42. DA COSTA PM, Nunes PIG, Ciurleo GCV, Junior JWLT, et al
    The Role of Extracellular Vesicles as Diagnostic Tools in Gut-Brain Axis Disorders.
    Mol Neurobiol. 2026;63:349.
    Abstract
    
    
43. NAKANISHI T, Drueke TB, Kuragano T
    Mechanism of reduced intestinal phosphate absorption by tenapanor: a hypothesis.
    Clin Kidney J. 2025;19:sfaf375.
    Abstract
    
    
44. LAMBIASE C, Rettura F, Sciume GD, Tedeschi R, et al
    Targeting gamma-aminobutyric acid pathways in irritable bowel syndrome: bridging central nervous system, enteric dysfunction, and the microbiota-gut-brain axis.
    Front Pharmacol. 2025;16:1677037.
    Abstract
    
    
45. ALHAJAJI R, Alfahmi M, Alshareef EM, Salim AMK, et al
    Does amitriptyline help for irritable bowel syndrome pain management?: An updated systematic review and meta-analysis.
    Medicine (Baltimore). 2026;105:e46869.
    Abstract
    
    
46. BRUNO A, Saccoccio V
    Improvement of Gastrointestinal Symptoms After Diastasis Recti Repair: A Prospective Study.
    Aesthetic Plast Surg. 2026 Jan 5. doi: 10.1007/s00266-025-05588.
    Abstract
    
    
47. GASPERI M, Gerstenberger A, Naliboff B, Afari N, et al
    Exploring Sex Differences in Irritable Bowel Syndrome Prevalence, Environmental Risk, and Comorbidities: A Population-Based Cohort Study of Veterans.
    Clin Transl Gastroenterol. 2026 Jan 5. doi: 10.14309/ctg.0000000000000967.
    Abstract
    
    
48. BALLENA-CAICEDO J, Valladolid-Sandoval LAM, Zuzunaga-Montoya FE, Vera-Ponce VJ, et al
    Global Prevalence of Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.
    Gastroenterology Res. 2025;18:308-321.
    Abstract
    
    
49. HU S, Xu Y, Chen J, Zhang L, et al
    Efficacy and safety of acupuncture for chemotherapy-induced diarrhea in colorectal cancer patients: a protocol for a systematic review and meta-analysis.
    Syst Rev. 2026 Jan 17. doi: 10.1186/s13643-026-03074.
    Abstract
    
    
50. SAINI U, Aggen SH, Oldehinkel AJ, Rosmalen JGM, et al
    Disentangling comorbidity: symptom dimensions of internalizing and functional disorders in a large general population sample.
    BMC Psychiatry. 2026 Jan 16. doi: 10.1186/s12888-026-07797.
    Abstract
    
    
51. LI Y, Liu S, Zhang Q, Zhang S, et al
    Maternal Smoking, Lactation and Risk of Incident Irritable Bowel Syndrome in Offspring: A Large-scale Prospective Cohort Study.
    Am J Clin Nutr. 2026 Jan 14:101200. doi: 10.1016/j.ajcnut.2026.101200.
    Abstract
    
    
52. CHEUNG SLY, Kenway LC
    Pathophysiological Mechanisms and Nonpharmacological Interventions in Irritable Bowel Syndrome: Current Insights and Future Directions.
    J Nutr Metab. 2026;2026:4520019.
    Abstract
    
    
53. CHENG J, Zhang T, Cui X, Wu P, et al
    Identification and Quantification of Structurally Related Peptide Impurity in Linaclotide by Liquid Chromatography-High Resolution Mass Spectrometry.
    Rapid Commun Mass Spectrom. 2026;40:e70030.
    Abstract
    
    
54. MORAIS T, Couto G, Rocha R, Santana G, et al
    PHARMACOLOGICAL TREATMENTS FOR FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTEGRATIVE REVIEW.
    Arq Gastroenterol. 2026;62:e25081.
    Abstract
    
    
55. MAGGO J, Ng HM, Bayer SB, Wall CL, et al
    Normalization of Gastrointestinal Symptoms in Adults With Constipation With Daily Green Kiwifruit Consumption: Protocol for an Open-Label Intervention Study.
    JMIR Res Protoc. 2026;15:e75286.
    Abstract
    
    
56. MILLER CB, Bader GA, Kay CL
    Fecal Microbiota Transplantation in 2025: Two Steps Forward, One Step Back.
    Curr Gastroenterol Rep. 2026;28:5.
    Abstract
    
    
57. LADEWSKI AM, Orleck KD, Skarbinski KF
    Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations.
    J Am Assoc Nurse Pract. 2026 Jan 13. doi: 10.1097/JXX.0000000000001218.
    Abstract
    
    
58. MATHEW GT, Novak P
    Prevalence of Central Sensitization in Postural Tachycardia Syndrome.
    JAMA Netw Open. 2026;9:e2553694.
    Abstract
    
    
59. ALI S, Banda A, Ramirez-Matos C, Cohen P, et al
    From Years of Pain to a Name: Fibromyalgia Uncovered.
    Cureus. 2025;17:e98981.
    Abstract
    
    
60. LIU Y, Yan X, Yang J, Zhang D, et al
    Efficacy and safety of non-pharmacological therapies for irritable bowel syndrome with diarrhoea: protocol for systematic review and network meta-analysis.
    BMJ Open. 2026;16:e105579.
    Abstract
    
    
61. DIMIDI E, Whelan K, Scott SM
    Dietary guidelines for gastrointestinal disorders: key to optimizing practice but more work needed.
    Nat Rev Gastroenterol Hepatol. 2026 Jan 22. doi: 10.1038/s41575-025-01171.
    Abstract
    
    
62. MIKO S, Kache PA, Imada E, Freeland AL, et al
    Postinfectious Syndromes and Long-Term Sequelae after Giardia Infections.
    Emerg Infect Dis. 2025;31:45-52.
    Abstract
    
    
63. CHATZOPOULOU MS, Vumma R, Prado S, Scharf MW, et al
    Development of a novel humanized gut-brain axis model as a tool toward personalized nutrition.
    Commun Biol. 2026;9:73.
    Abstract
    
    
64. FARSI DN, Whelan K, Dimidi E
    Perceptions of the Role of Diet Among People With Constipation: Dietary Contributors and Relievers to Symptoms and Research Priorities.
    J Hum Nutr Diet. 2026;39:e70201.
    Abstract
    
    
65. YEH ST, Li MY, Chen YC
    Mental and physical health outcomes among intimate partner violence survivors in Taiwan: A nationwide registry-based case control study.
    World J Psychiatry. 2026;16:112745.
    Abstract
    
    
66. SUGAYA N, Izawa S, Sasaki T
    Effects of irritable bowel syndrome and related cognitive-behavioral and occupational stress factors on the productivity and abdominal symptoms of Japanese workers: a longitudinal study.
    Biopsychosoc Med. 2026 Jan 19. doi: 10.1186/s13030-026-00349.
    Abstract
    
    
67. LYU D, Wang X, Zhang J, Fu S, et al
    Glucocorticoid signaling mitigates colitis-associated visceral hypersensitivity by suppressing 5-HT release in enterochromaffin cells via a GR-PI3K-SGK1 axis.
    Int Immunopharmacol. 2026;172:116207.
    Abstract
    
    
68. KRUEGER A, Waheed U, Santucci N
    Overlap of Structural Gastrointestinal Disorders in Children With Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2026;38:e70231.
    Abstract
    
    
69. MULAK A
    The Hidden Role of Dreams and Nightmares in Gastrointestinal Disorders: Exploring a Nocturnal Blind Spot in Sleep Research.
    Neurogastroenterol Motil. 2026;38:e70240.
    Abstract
    
    
70. ZHUANG Z, Lv B, Chen Y, Chen J, et al
    The effect of Massa Medicata Fermentata on the cytokine secretion of colonic mucosa and visceral sensitivity in rats with IBS-D.
    Front Cell Infect Microbiol. 2026;15:1616796.
    Abstract
    
    
71. HONG J, Ji R, Wang P, Huang F, et al
    A set of downregulated pleiotropic genes are possible multi-omics biomarkers underlying the irritable bowel syndrome-non-alcoholic fatty liver disease comorbidity.
    Am J Transl Res. 2025;17:9494-9515.
    Abstract
    
    
72. KUMAR A, Sarangi Y, Kaw P
    Gene, genetics and genetic medicines in gastroenterology: Current status and its future.
    World J Gastroenterol. 2026;32:112496.
    Abstract
    
    
73. BOGDANOWSKA-CHARKIEWICZ D, Malinowska U, Daniluk J
    An umbrella review of meta-analyses on the low-FODMAP diet in IBS.
    Front Nutr. 2026;12:1714281.
    Abstract
    
    
74. JIN R, Zhou Z, Lou Y, Wang X, et al
    Peoniflorin Alleviates Corticotropin-Releasing Factor-Induced Irritable Bowel Syndrome by Improving the Intestinal Barrier Function through the Inhibition of the CRFR1/ROCK2/MLC Signaling Pathway.
    J Agric Food Chem. 2026 Jan 19. doi: 10.1021/acs.jafc.5c10339.
    Abstract
    
    
75. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
    Bombesin improves visceral hypersensitivity and colonic hyperpermeability via BB(1) receptor-dependent multi-pathway mechanisms in a rat model of irritable bowel syndrome.
    Eur J Pharmacol. 2026;1015:178566.
    Abstract
    
    
76. DAMIANOS JA, Wang XJ, Camilleri M
    Mechanisms and pathophysiology leading to development of small intestinal microbial dysbiosis.
    Lancet Gastroenterol Hepatol. 2026 Jan 14:S2468-1253(25)00295.
    Abstract
    
    
77. SILVA H, Zheng T, Porter J, Barrett J, et al
    The Associations of Sucrase-Isomaltase Hypomorphic Variants With Long-Term Outcomes and Dietary Intake in an Australian Irritable Bowel Syndrome Population Educated on the FODMAP Diet: A Cross-Sectional and Retrospective Study.
    United European Gastroenterol J. 2026;14:e70173.
    Abstract
    
    
78. PONTES-SILVA A
    Heterogeneity and patient stratification in fibromyalgia and irritable bowel syndrome treatment studies: systematic review discussion.
    Clin Rheumatol. 2026 Jan 17. doi: 10.1007/s10067-026-07953.
    Abstract
    
    
79. BAI W, Zheng Y, Lin S, Pan Y, et al
    Child maltreatment and its association with incident irritable bowel syndrome: genetic risk and mediation pathways in the UK biobank.
    J Public Health (Oxf). 2026 Jan 30:fdag004. doi: 10.1093.
    Abstract
    
    
80. VERMEIJDEN NK, van der Feen C, Groeneweg M, Hummel T, et al
    Peppermint oil and sweets in pediatric irritable bowel syndrome and functional abdominal pain: a randomized trial.
    Clin Gastroenterol Hepatol. 2026 Jan 27:S1542-3565(26)00042.
    Abstract
    
    
81. HUGHES M, Jude E, McMahan ZH, Alam U, et al
    An epidemiological study estimating the burden of cancer risk in patients with Raynaud's phenomenon.
    Clin Rheumatol. 2026 Jan 29. doi: 10.1007/s10067-026-07961.
    Abstract
    
    
82. UPPALA PK, Karanam SK, Maddi R
    Science of fecal microbiota transplant: From history to cutting-edge clinical practice.
    World J Gastrointest Endosc. 2026;18:113133.
    Abstract
    
    
83. JANOWSKI WM, Kaczmarczyk GM, Tarasiuk-Zawadzka A, Fichna J, et al
    Therapeutic strategies in irritable bowel syndrome: current standards, emerging options and future challenges.
    Folia Med Cracov. 2025;65:5-29.
    Abstract
    
    
84. DING Y, Wang J, Luo Q, Deng C, et al
    Shared genetic architecture between schizophrenia and gastrointestinal diseases: insights from large-scale genome-wide cross-trait analysis.
    Ann Gen Psychiatry. 2026 Jan 28. doi: 10.1186/s12991-025-00625.
    Abstract
    
    
85. KOU RW, Zhang RJ, Xia B, Bai GY, et al
    Ganoderic Acid A Modulates Enteric Neurons and Intestinal Homeostasis in Irritable Bowel Syndrome by Microbiota Sensing.
    J Agric Food Chem. 2026 Jan 28. doi: 10.1021/acs.jafc.5c15628.
    Abstract
    
    
86. ZHOU Y, Liu S, Xie S, Zhang Q, et al
    Long-term risk of irritable bowel syndrome associated with adverse childhood and adulthood experiences: a large-scale prospective cohort study.
    Transl Psychiatry. 2026 Jan 28. doi: 10.1038/s41398-026-03833.
    Abstract
    
    
87. HOU S, Ning T, Liu S, Yang X, et al
    Fusobacterium nucleatum plays a pathogenic role in a murine model of irritable bowel syndrome by modulating intestinal purine metabolism and promoting mast cell activation.
    Gut Microbes. 2026;18:2620124.
    Abstract
    
    
88. ACCARIE A, Huyghe P, Meleine M, Van den Houte K, et al
    Oral Local Budesonide Treatment Ameliorates Immune Activation and Colonic Sensitivity in a Spontaneous Model for Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2026;38:e70233.
    Abstract
    
    
89. PIA F, Decraecker L, Looze D, Hirsch D, et al
    Dose-Dependent Effect of the Histamine 1 Receptor Antagonist Ebastine in Patients With Non-Constipated Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2026;38:e70242.
    Abstract
    
    
90. SMITH SJ, Sichlau MJ, Rowe PC, Knight DRT, et al
    Case Report: Neuropsychiatric improvement after treatment of pelvic venous disorder in a multisyndromic patient.
    Front Cardiovasc Med. 2026;12:1574432.
    Abstract
    
    
91. LACY BE, Shin AS, Cangemi DJ, Yang Y, et al
    Tenapanor is associated with earlier and sustained symptom relief in IBS-C: a post hoc analysis.
    Therap Adv Gastroenterol. 2026;19:17562848251414831.
    Abstract
    
    
92. SONG CH, Kim N, Nam RH, Choi H, et al
    Sex-Dependent Microbial and Host Profiles Following Fecal Microbiota and Bifidobacterium longum Treatment in Stress-Induced Gut Dysbiosis.
    Gut Liver. 2026 Jan 28. doi: 10.5009/gnl250440.
    Abstract
    
    
93. PASTRAS P, Aggeletopoulou I, Bali M, Triantos C, et al
    Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
    Nutrients. 2026;18:183.
    Abstract
    
    
94. LIM YH, Yoo JH, Park JW, Hwang JM, et al
    Gastrointestinal Diagnostic Coding After Spinal Cord Injury: Health Behavior Correlates and Implications for Neurogenic Bowel Management in a Nationwide Claim-Based Cohort.
    J Clin Med. 2026;15:760.
    Abstract
    
    
95. SACCO R, Facciorusso A, Giannini E, Bellini M, et al
    Revisiting Abdominal Pain in IBS: From Pathophysiology to Targeted Management with Alverine Citrate/Simeticone.
    J Clin Med. 2026;15:722.
    Abstract
    
    
96. PICCIRILLO M, Renzi E, De Vito C, Mennini M, et al
    Efficacy and Safety of Probiotics in Children with Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Microorganisms. 2025;14:23.
    Abstract
    
    
97. ALMALKI AS, Jaafari NY, Aldossari NG, Alharbi AA, et al
    Efficacy of Specific Probiotic Strains in Subtypes of Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Medicina (Kaunas). 2025;62:89.
    Abstract
    
    
98. ZHU Z, Liu Z, He Y, He X, et al
    G Protein-Coupled Receptors in Irritable Bowel Syndrome: Mechanisms and Therapeutic Opportunities.
    Int J Mol Sci. 2026;27:752.
    Abstract
    
    
99. JIA SM, Wang KQ, Hu SF, Weng RX, et al
    A Glutamatergic Medial Prefrontal Cortex-Locus Coeruleus Circuit Drives Intestinal Dysmotility in Diarrhea-Predominant Irritable Bowel Syndrome.
    Int J Mol Sci. 2026;27:681.
    Abstract
    
    
100. LUNDERVOLD A, Billing J, Berentsen B, Lundervold AJ, et al
     Patient Similarity Networks for Irritable Bowel Syndrome: Revisiting Brain Morphometry and Cognitive Features.
     Diagnostics (Basel). 2026;16:357.
     Abstract
     
     
101. ZHAO Y, Zhang Y, Gao Z, Yuan X, et al
     Effect of combined continuity care guided by Orem's self-care model and low FODMAP diet on gut microbiota composition and symptoms in patients with irritable bowel syndrome.
     BMC Gastroenterol. 2026 Jan 28. doi: 10.1186/s12876-026-04621.
     Abstract
     
     
102. RAMEZANI A, Yazdanmanesh M, Heidari H, Khadiv A, et al
     Phenotypic and Genotypic Characterization of ESBL- and Carbapenemase-producing Escherichia coli Isolates in Irritable Bowel Syndrome (IBS) Patients.
     Infect Disord Drug Targets. 2026.
     Abstract
     
     
103. KOCA TT, Gogebakan H, Nazik H, Cetin G, et al
     Clinical Importance of Central Sensitization and Neuropathic Pain in The Treatment and Follow-Up of Patients with Psoriasis and Psoriatic Arthritis.
     Indian J Dermatol. 2026;71:58-64.
     Abstract
     
     
104. KIM Y, Lee MH, Seo SH, Pak J, et al
     Integrated Metabolomics and Microbial Profiling in Patients with Irritable Bowel Syndrome.
     J Microbiol Biotechnol. 2026;36:e2511041.
     Abstract
     
     
105. GHOSHAL UC, Singh R, Goenka MK
     Post-Coronavirus Disease (COVID)-19 Irritable Bowel Syndrome: What We've Learned So Far.
     Neurogastroenterol Motil. 2026;38:e70250.
     Abstract
     
     
106. HERNANDO A, Morais Costa B, Charneca S, Santos I, et al
     Mapping the Evidence on IgG-Based Elimination Diets for the Management of Irritable Bowel Syndrome in Adults: A Systematic Scoping Review.
     Nutr Rev. 2026 Jan 24:nuaf268. doi: 10.1093.
     Abstract
     
     
107. BADWEI N, Abdelsalam A, Wassif GO, El-Din HES, et al
     Quality of Life and Psychological Burden in Irritable Bowel Syndrome: The Impact of Intestinal Parasitic Infections (Phase II Study).
     Trop Med Int Health. 2026 Jan 23. doi: 10.1111/tmi.70079.
     Abstract
     
     
108. ZHENG NS, Bar N, Kuo B, Staller K, et al
     Research Communication: Healthcare Utilisation Patterns in Patients With Irritable Bowel Syndrome Across an Integrated Healthcare System.
     Aliment Pharmacol Ther. 2026;63:294-298.
     Abstract
     
     
109. KHASAWNEH M, Goodoory VC, Ng CE, Ford AC, et al
     Stability of Classification Systems for Irritable Bowel Syndrome.
     Aliment Pharmacol Ther. 2025 Dec 25. doi: 10.1111/apt.70503.
     Abstract
     
     
110. ALSAKARNEH S, Al Ta'ani O, Mahmoud MY, Syn WK, et al
     Comprehensive Risk Profile of Gastrointestinal and Extra Articular Comorbidities in Ehlers-Danlos Syndrome: A Propensity-Matched Analysis of 118,256 Individuals.
     Aliment Pharmacol Ther. 2025 Dec 23. doi: 10.1111/apt.70506.
     Abstract
     
     
111. ZHANG M, Wellens J, Zhao J, Ji H, et al
     Psychological Resilience and Mental Wellbeing Mitigate the Risk of Irritable Bowel Syndrome.
     Am J Gastroenterol. 2025 Nov 19. doi: 10.14309/ajg.0000000000003833.
     Abstract
     
     
112. GUTIERREZ-TORRES DS, Li F, Liao LM, Daniel CR, et al
     The Time-Dependent Association Between Irritable Bowel Syndrome and All-Cause and Cause-Specific Mortality in the NIH-AARP Cohort Study.
     Am J Gastroenterol. 2025 Nov 21. doi: 10.14309/ajg.0000000000003861.
     Abstract
     
     
113. CENTOR RM, Aziz I
     Annals On Call - Mediterranean Diet in the Management of Irritable Bowel Syndrome.
     Ann Intern Med. 2026 Jan 6:e2505558OC. doi: 10.7326/ANNALS-25-05558.
     Abstract
     
     
114. CHANG A, Shahrvini B, Oh J, Prajapati DP, et al
     Increased Autoimmunity Burden Is a Risk Factor for Developing Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease.
     Dig Dis Sci. 2026 Jan 3. doi: 10.1007/s10620-025-09633.
     Abstract
     
     
115. MCSHANE C, O'Connell F, Kevans D, O'Sullivan J, et al
     Ex Vivo Human Colonic Explants Identify Metabolic Alterations and Cytokine Dysregulation in Ulcerative Colitis: A Pilot Study.
     Dig Dis Sci. 2026 Jan 26. doi: 10.1007/s10620-025-09665.
     Abstract
     
     
116. ANWAR DFF, Salma ZN, Oktaviani SD, Adiyatma FN, et al
     Effect of multistrain probiotics on symptom severity in irritable bowel syndrome: a systematic review and meta-analysis of irritable bowel syndrome-symptom severity score outcomes.
     Eur J Gastroenterol Hepatol. 2025 Dec 24. doi: 10.1097/MEG.0000000000003074.
     Abstract
     
     
117. AKRAM U, Ul Ain H, Ahmed S, Fatima E, et al
     Efficacy and tolerability of plecanatide for irritable bowel syndrome with constipation and chronic idiopathic constipation: a systematic review and meta-analysis.
     Eur J Gastroenterol Hepatol. 2026 Jan 13. doi: 10.1097/MEG.0000000000003115.
     Abstract
     
     
118. GUAN M, Chang L
     Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use.
     Gastroenterol Clin North Am. 2026;55:91-105.
     Abstract
     
     
119. DIAZ-MUNOZ C, Bozzarelli I, Lopera-Maya EA, Belbasis L, et al
     Genetic dissection of stool frequency implicates vitamin B1 metabolism and other actionable pathways in the modulation of gut motility.
     Gut. 2026 Jan 20:gutjnl-2025-337059. doi: 10.1136/gutjnl-2025-337059.
     Abstract
     
     
120. MARASCO G, Schmulson M, Ghoshal UC, Khatun R, et al
     Post-infection disorders of gut-brain interaction: results of the Rome Foundation Global Epidemiology Study.
     Gut. 2026 Jan 29:gutjnl-2025-336509. doi: 10.1136/gutjnl-2025-336509.
     Abstract
     
     
121. BRINDICCI VF, Cristofori F, Franceschini S, Gnasso I, et al
     Self-reported Nonceliac Gluten Sensitivity in Patients With Irritable Bowel Syndrome: A Cross-sectional Analysis.
     J Clin Gastroenterol. 2026 Jan 30. doi: 10.1097/MCG.0000000000002306.
     Abstract
     
     
122. MACK A, Halmos EP, Mogilevski T, Anderson EJ, et al
     A Critical Review of Persistent Gastrointestinal and Extraintestinal Symptoms in Quiescent Inflammatory Bowel Disease: Time for Greater Precision and Clarity.
     J Gastroenterol Hepatol. 2026 Jan 18. doi: 10.1111/jgh.70223.
     Abstract
     
     
123. CRISTOFORI F, Calabrese FM, De Angelis M, Francavilla R, et al
     Data over doubt: Clarifications on calcium butyrate efficacy in pediatric irritable bowel syndrome.
     J Pediatr Gastroenterol Nutr. 2025 Dec 30. doi: 10.1002/jpn3.70326.
     Abstract
     
     
124. VERMEIJDEN NK, Gordon M, Benninga M, Vlieger A, et al
     Analysis of "Calcium butyrate efficacy in pediatric irritable bowel syndrome".
     J Pediatr Gastroenterol Nutr. 2025 Dec 30. doi: 10.1002/jpn3.70328.
     Abstract
     
     
125. YOUNGINER ST, Westbrook A, Buzenski J, Dykes C, et al
     Health-related quality of life in youth with chronic gastrointestinal disease following a biofeedback enhanced cognitive behavioral therapy intervention: A randomized controlled trial.
     J Pediatr Gastroenterol Nutr. 2026 Jan 4. doi: 10.1002/jpn3.70333.
     Abstract
     
     
126. PASRICHA PJ, Talley NJ
     Functional Dyspepsia.
     N Engl J Med. 2026;394:166-176.
     Abstract
     
     
127. GUO D, Song Y, Yuan L, Chu W, et al
     The gut-Joint axis: investigating functional gastrointestinal disorders as risk factors for prosthetic joint infections a retrospective case-control study.
     Postgrad Med. 2026 Jan 21:1-6. doi: 10.1080/00325481.2026.2619422.
     Abstract
     
     
128. HAMBERG LEVEDAHL K, Carlson M, Nilsson GP, Jakobsson Larsson B, et al
     Investigating instruments for evaluation of gastrointestinal burdens in patients with systemic mastocytosis: an exploratory multimethod study.
     Scand J Gastroenterol. 2025 Dec 21:1-10. doi: 10.1080/00365521.2025.2604778.
     Abstract
     
     
129. DEMIR E, Tunc A, Baser B, Mermer S, et al
     Genetic sucrase-isomaltase deficiency: epidemiology, clinical spectrum, and diagnostic challenge.
     Scand J Gastroenterol. 2026 Jan 12:1-9. doi: 10.1080/00365521.2026.2615396.
     Abstract
     
     
130. ROHNER S, Schnepper R, Meienberg A, Bopp K, et al
     Protocol of the digital long COVID study: A single-center, registry-based, feasibility and clinical evaluation study to investigate a 12-week digital intervention program for people affected by post-COVID-19 condition.
     PLoS One. 2026;21:e0340385.
     Abstract